NanoBiotech
1023.651.490 · rovalta.com · 24/09/2026
NanoBiotech
Overview
What does NanoBiotech do?
NanoBiotech is a Private limited company incorporated in 2025. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Diepenbeek.
3590 Diepenbeek · FlandreSee on map
Trend over 1 financial year
| 2025 | |
|---|---|
| Income statement | |
| Gross margin | -31,2 k € |
| EBITDA | -31,6 k € |
| Operating result | -31,6 k € |
| Net result | -31,6 k € |
| Balance sheet | |
| Equity | -26,1 k € |
| Total assets | 1,8 k € |
| Cash | 30,9 € |
| Debts | 28 k € |
Board of directors
Seen on filing of 31/12/2025 · 3 active
Active mandates
Other companies at this address
| Company | CBE no. |
|---|---|
Bedal International● Active | 0841.685.826 |
BIOCLUE● Active | 0719.914.105 |
BIOKEY● Active | 0719.913.808 |
BIOSTRAND● Active | 0719.913.907 |
Clinitude● Active | 0478.640.857 |
C-Path● Active | 0762.683.482 |
FOx Biosystems● Bankrupt | 0653.744.366 |
Highstar Engineering● Active | 0685.983.703 |
IDEA FAMILY● Active | 0719.674.177 |
Presscuff● Active | 0800.361.153 |
Reprosci Biosciences● Active | 1008.398.241 |
Sealantium Medical Belgium● Active | 1012.599.727 |
SIMABS● Active | 0732.709.096 |
| 1011.224.604 | |
StingOrg● Active | 0804.587.383 |
Financials
Full financial information
| 2025 | |
|---|---|
| Type of account | Micro model |
| Start of the financial year | 23/05/2025 |
| Closing of the financial year | 31/12/2025 |
| Length of the financial year | 8 months |
| Filing date | 10/09/2026 |
| General meeting | 15/06/2026 |
| Currency of the financial year | EUR |
| NBB quality label | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
1 filing with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 15/06/2026 | 10/09/2026 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 3 active
Active mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Other27/05/2025OPRICHTING
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-31,6 k €
- 23/05/2025IncorporationPrivate limited company